Glenmark Pharma gets USFDA nod for generic drug

The company's US-based subsidiary has received final approval from the
US Food and Drug Administration (USFDA) for the product which is a
generic version of PF Prism CV's Rapamune tablets, Glenmark
Pharmaceuticals said in a statement.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/glenmark-pharma-gets-usfda-nod-for-generic-drug/articleshow/78742920.cms

Comments

Popular posts from this blog

Clinical Database Management Professional Vacancy @ Teva

Pharma Production Executive Post Vacancy @ Intas

Biotecnika Times – Newsletter 28.02.2020 – DST Women Scientist WOS B, DBT-IOC Recruitment